Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523954 Target Snapshot

Nonstructural protein 3 · SINGLE PROTEIN · Zika virus

5,715Compounds
63Assays
7Approved Drugs
3,698.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt A0A024AXB9. Use UniProt A0A024AXB9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt A0A024AXB9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Nonstructural protein 3 as ChEMBL target CHEMBL4523954, mapped to UniProt A0A024AXB9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Nonstructural protein 3
SINGLE PROTEIN · Zika virus
As of 2026-09-14
ChEMBL target ID
CHEMBL4523954
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
A0A024AXB9
Nonstructural protein 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Nonstructural protein 3 is the right protein anchor across sources, using UniProt A0A024AXB9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNonstructural protein 3
UniProt AccessionA0A024AXB9
Component TypeProtein
Sequence Length66 aa

Nonstructural protein 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Nonstructural protein 3, mapped to UniProt A0A024AXB9. Sequence length is 66 aa.

Mapped IDA0A024AXB9
Review nameNonstructural protein 3
OrganismZika virus
Clinical Profile

Clinical Phase Distribution

7
Approved
7
Phase III
3
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC503,653.0
KI24.0
EC5010.0
KD11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5267698 8.77 Ki 1.7 Preclinical
CHEMBL4589938 8.3 Kd 5.0 Preclinical
CHEMBL4555617 8.1 Kd 8.0 Preclinical
CHEMBL4452943 8.05 Kd 9.0 Preclinical
CHEMBL4454475 8.05 Kd 9.0 Preclinical
CHEMBL5604470 8.0 IC50 10.0 Preclinical
CHEMBL5604216 7.89 IC50 13.0 Preclinical
CHEMBL5604355 7.89 IC50 13.0 Preclinical
CHEMBL5604627 7.89 IC50 13.0 Preclinical
CHEMBL5605274 7.89 IC50 13.0 Preclinical
Distribution

pChEMBL Value Distribution

279
5.0
257
5.5
158
6.0
177
6.5
178
7.0
94
7.5
5
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TEMOPORFIN
CHEMBL500576
Approved 2001
Assay Landscape

Assay Landscape

63
Total Assays
1,088
Tested Compounds
2
Assay Types
Binding — 58 assays, 278 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 26 228 5.5
single protein format 17 29 6.2
cell-based format 15 21 5.6
Functional — 5 assays, 1,088 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 1,088 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine